University of Virginia
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Virginia sits in the top decile of US sponsors by registered trial count (#78 of 15,742 sponsors by registered trial count).
University of Virginia: 449 sponsored US clinical trials, 101 recruiting.
University of Virginia sponsors 449 registered US clinical trials on ClinicalTrials.gov, 101 of them currently recruiting, and 281 completed. 40 of these trials are in Phase 3-4 (later-stage) and 109 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 1 Diabetes Mellitus, with 9 trials.
Top-decile sponsor footprint
University of Virginia ranks in the top decile of sponsors by registered trial count (#78 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
281 of 317 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
449 total, page 2 of 9
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia
NCT05660525
Support Via Online Social Networks to Promote Safe Infant Care Practices
NCT05767658
The Influence of Prescribed Exercise on Pain Related Fear Following Concussion in Collegiate Athletes
NCT06246669
Tremor Retrainer Software Application for Functional Tremor
NCT06257069
Text-Based Messaging Strategies for Preventing Subsequent Problematic Alcohol Use
NCT06318975
Optimizing Pain Self-Management in Total Knee Arthroplasty
NCT06038240
Organic Compounds and Postoperative Delirum
NCT05875220
Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
NCT05653518
Implementation Supports for Improving Identification and Delivery of School-based Mental Health Supports for Middle Schools Students
NCT06047041
Associations Between the Microbiome, Skeletal Muscle Perfusion, and Fitness Status
NCT06009276
Pessary Experience Study
NCT06021769
Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease
NCT05762952
PRIME HFrEF: Novel Exercise for Older Patients With Heart Failure With Reduced Ejection Fraction
NCT05609097
Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)
NCT05790850
Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy
NCT05860725
Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
NCT05565833
Platelet Adhesion in the Pathobiology of Aortic Stenosis
NCT05550896
Ultrasound Cavitation Therapy for CLI
NCT05749250
Gut Microbiome and Blood Indices in Patients With AD and Their Spousal Caregivers
NCT05601856
Insula Neuromodulation for Chronic Neuropathic Pain
NCT05404581
Simplified Post Op Rehabilitation for Ankle and Pilon Fractures
NCT05280639
PENG vs FICB for Hip Fracture in ED Patients
NCT05505604
Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
NCT05094570
Effect of Nitropaste in Chest Masculinizing Surgery
NCT06428669
Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above
NCT05404945
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
NCT05288777
Effect of Melatonin on Sleep Patterns of Resident Trainees During Night Float Shift
NCT05701969
Viral Infection in Asthma (VIA) Study
NCT04380038
The Effect of a High Fiber Diet and High-Intensity Interval Exercise in Patients With HFpEF
NCT05236413
Cardioprotection in AML
NCT04977180
Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?
NCT04723862
Obesity and Pediatric Multiple Sclerosis
NCT04593082
Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
NCT04305769
Characterization of the Pudendal Nerve with Transvaginal Ultrasonography
NCT06021782
Reduction in Number of Botox Injections for Urgency Urinary Incontinence
NCT04731961
Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL
NCT04747236
Hyperpolarized Xenon-129 MR Imaging of the Lung
NCT04662658
4D-MRI for Precision Medicine
NCT04657042
Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome
NCT04575844
Mycobacterial Lung Diseases in Virginia: Sequencing and Clinical Determinants of Relapse and Outcome
NCT05277857
EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer
NCT04465500
Magnesium and Riboflavin Treatment for Post-Concussion Headache
NCT06260072
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
NCT03905603
Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening
NCT04904757
Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection
NCT07046910
Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy
NCT03331302
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
NCT03161223
Mechanistic Clinical Trial of Advanced Imaging for CRT
NCT03398369
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
NCT03401047
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
NCT03068910
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 58 |
| Phase 2 | 51 |
| Phase 3 | 14 |
| Phase 4 | 26 |
Therapeutic Areas
What is open in the University of Virginia pipeline
101 recruiting of 449 indexed (22% open); 281 completed (63%).
Phase mix: 40 late (III/IV) vs 109 early (I/II) (early-phase heavy).
Top condition: Type 1 Diabetes Mellitus (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Virginia: open-pipeline peers nationwide
Peers matched on 449 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
University of Virginia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 449 trials (± recruiting share)
- Medical College of Wisconsin · 447 trials · 21% recruiting
- Alliance for Clinical Trials in Oncology · 446 trials · 7% recruiting
- Boston Children's Hospital · 462 trials · 24% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
Sponsors near 22% open enrollment (± trial volume)
- Ohio State University Comprehensive Cancer Center · 23% recruiting · 341 trials
- University of Delaware · 23% recruiting · 106 trials
- University of Oklahoma · 22% recruiting · 358 trials
- ALX Oncology · 22% recruiting · 9 trials
Related
What to do with this University of Virginia page
449 registered trials is a research-attention snapshot, not an endorsement of University of Virginia or any single study.
- 101 of University of Virginia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 1 Diabetes Mellitus is the condition University of Virginia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 1 Diabetes Mellitus trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Virginia pipeline card: 449 registered trials from official public datasets.Report a data error.